BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 19186028)

  • 1. Hypnosis for postradiation xerostomia in head and neck cancer patients: a pilot study.
    Schiff E; Mogilner JG; Sella E; Doweck I; Hershko O; Ben-Arye E; Yarom N
    J Pain Symptom Manage; 2009 Jun; 37(6):1086-1092.e1. PubMed ID: 19186028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical stimulation of post-irradiated head and neck squamous cell carcinoma to improve xerostomia.
    Pattani KM; McDuffie CM; Morgan M; Armstrong C; Nathan CO
    J La State Med Soc; 2010; 162(1):21-5. PubMed ID: 20336953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.
    Lin SC; Jen YM; Chang YC; Lin CC
    J Pain Symptom Manage; 2008 Aug; 36(2):141-8. PubMed ID: 18395402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients.
    Kakoei S; Haghdoost AA; Rad M; Mohammadalizadeh S; Pourdamghan N; Nakhaei M; Bahador M
    Arch Iran Med; 2012 Apr; 15(4):214-8. PubMed ID: 22424038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
    Braam PM; Roesink JM; Raaijmakers CP; Busschers WB; Terhaard CH
    Radiat Oncol; 2007 Jan; 2():3. PubMed ID: 17207274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study.
    Garcia MK; Chiang JS; Cohen L; Liu M; Palmer JL; Rosenthal DI; Wei Q; Tung S; Wang C; Rahlfs T; Chambers MS
    Head Neck; 2009 Oct; 31(10):1360-8. PubMed ID: 19378325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
    Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
    N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
    Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
    J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
    Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
    Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
    Meirovitz A; Murdoch-Kinch CA; Schipper M; Pan C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):445-53. PubMed ID: 16839705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
    Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
    J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
    Jellema AP; Slotman BJ; Muller MJ; Leemans CR; Smeele LE; Hoekman K; Aaronson NK; Langendijk JA
    Cancer; 2006 Aug; 107(3):544-53. PubMed ID: 16804929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
    Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
    Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.